More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

A new study has found that weight loss drugs may significantly reduce the consumption of alcohol in those with alcohol use ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...